Literature DB >> 35655102

An apoptosis inhibitor suppresses microglial and astrocytic activation after cardiac ischemia/reperfusion injury.

Suchan Liao1,2,3, Ying Luo1,2,3, Titikorn Chunchai1,2, Kodchanan Singhanat1,2,3, Busarin Arunsak1,2, Juthipong Benjanuwattra1,2, Nattayaporn Apaijai1,2,3, Nipon Chattipakorn1,2,3, Siriporn C Chattipakorn4,5,6.   

Abstract

OBJECTIVE: Microglial hyperactivation and apoptosis were observed following myocardial infarction and ischemia reperfusion (I/R) injury. This study aimed to test the hypothesis that the apoptosis inhibitor, Z-VAD, attenuates microglial and astrocytic hyperactivation and brain inflammation in rats with cardiac I/R injury.
MATERIALS AND METHODS: Rats were subjected to either sham or cardiac I/R operation (30 min-ischemia followed by 120-min reperfusion), rats in the cardiac I/R group were given either normal saline solution or Z-VAD at 3.3 mg/kg via intravenous injection 15 min prior to cardiac ischemia. Left ventricular ejection fraction (% LVEF) was determined during the cardiac I/R protocol. The brain tissues were removed and used to determine brain apoptosis, brain inflammation, microglial and astrocyte morphology.
RESULTS: Cardiac dysfunction was observed in rats with cardiac I/R injury as indicated by decreased %LVEF. In the brain, we found brain apoptosis, brain inflammation, microglia hyperactivation, and reactive astrogliosis occurred following cardiac I/R injury. Pretreatment with Z-VAD effectively increased %LVEF, reduced brain apoptosis, attenuated brain inflammation by decreasing IL-1β mRNA levels, suppressed microglial and astrocytic hyperactivation and proliferation after cardiac I/R injury.
CONCLUSION: Z-VAD exerts neuroprotective effects against cardiac I/R injury not only targeting apoptosis but also microglial and astrocyte activation.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Apoptosis inhibitor; Astrocyte; Cardiac ischemia/reperfusion injury; Microglia; Neuroinflammation

Mesh:

Year:  2022        PMID: 35655102     DOI: 10.1007/s00011-022-01590-2

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   6.986


  43 in total

1.  Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo.

Authors:  Axel Nimmerjahn; Frank Kirchhoff; Fritjof Helmchen
Journal:  Science       Date:  2005-04-14       Impact factor: 47.728

2.  Recommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary intervention.

Authors:  Alice K Jacobs; Elliott M Antman; Gray Ellrodt; David P Faxon; Tammy Gregory; George A Mensah; Peter Moyer; Joseph Ornato; Eric D Peterson; Larry Sadwin; Sidney C Smith
Journal:  Circulation       Date:  2006-03-28       Impact factor: 29.690

3.  Humanin prevents brain mitochondrial dysfunction in a cardiac ischaemia-reperfusion injury model.

Authors:  Sirinart Kumfu; Savitree T Charununtakorn; Thidarat Jaiwongkam; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Exp Physiol       Date:  2016-06-01       Impact factor: 2.969

4.  Hypoxic preconditioning attenuates necroptotic neuronal death induced by global cerebral ischemia via Drp1-dependent signaling pathway mediated by CaMKIIα inactivation in adult rats.

Authors:  Lixuan Zhan; Zhiwei Lu; Xinyong Zhu; Wensheng Xu; Luxi Li; Xinyu Li; Siyuan Chen; Weiwen Sun; En Xu
Journal:  FASEB J       Date:  2018-08-27       Impact factor: 5.191

5.  Donepezil provides neuroprotective effects against brain injury and Alzheimer's pathology under conditions of cardiac ischemia/reperfusion injury.

Authors:  Benjamin Ongnok; Thawatchai Khuanjing; Titikorn Chunchai; Sasiwan Kerdphoo; Thidarat Jaiwongkam; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-09-18       Impact factor: 5.187

6.  Mitochondrial Fusion Promoter Alleviates Brain Damage in Rats with Cardiac Ischemia/Reperfusion Injury.

Authors:  Poomarin Surinkaew; Nattayaporn Apaijai; Passakorn Sawaddiruk; Thidarat Jaiwongkam; Sasiwan Kerdphoo; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 7.  A review of myocardial ischaemia/reperfusion injury: Pathophysiology, experimental models, biomarkers, genetics and pharmacological treatment.

Authors:  Mehmet Gunata; Hakan Parlakpinar
Journal:  Cell Biochem Funct       Date:  2020-09-06       Impact factor: 3.685

8.  Microglia-mediated phagocytosis of apoptotic nuclei is impaired in the adult murine hippocampus after stroke.

Authors:  Max Rudolph; Christian W Schmeer; Madlen Günther; Florus Woitke; Carolin Kathner-Schaffert; Lina Karapetow; Julia Lindner; Thomas Lehmann; Gustav Jirikowski; Otto W Witte; Christoph Redecker; Silke Keiner
Journal:  Glia       Date:  2021-05-04       Impact factor: 7.452

9.  Pretreatment With PCSK9 Inhibitor Protects the Brain Against Cardiac Ischemia/Reperfusion Injury Through a Reduction of Neuronal Inflammation and Amyloid Beta Aggregation.

Authors:  Nattayaporn Apaijai; Dalila Monica Moisescu; Siripong Palee; Christian Mervyn McSweeney; Napatsorn Saiyasit; Chayodom Maneechote; Chiraphat Boonnag; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  J Am Heart Assoc       Date:  2019-01-22       Impact factor: 5.501

Review 10.  Microglial activation after ischaemic stroke.

Authors:  Shengxiang Zhang
Journal:  Stroke Vasc Neurol       Date:  2019-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.